White Papers

White Papers

Our white papers seek to promote understanding, encourage fresh thinking, and give readers a deep dive into a variety of trending topics around innovative drug development and manufacturing. Each is a natural extension of our dedication to match your needs and interests with our expertise and capabilities.  

How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology and Vaccines

Nanoparticles have experienced increasing demand in recent years in biopharmaceutical formulations, owing to their utility for...

READ MORE

Streamlining Your Process Development Journey to GMP Manufacturing

Many CDMOs specialize in certain parts of the drug development lifecycle. Meanwhile, integrated turn-key offerings that support...

READ MORE

Finding the Right CDMO Partner for Tech Transfer

Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents...

READ MORE

Utilizing Expertise & Experience for Successful Downstream Processing

Successful downstream processing provides isolation of the molecule of interest from extraneous constituents before formulation,...

READ MORE

Benefits of RABS and Isolator Technology in a Changing Regulatory Landscape

Mitigating risk is a key consideration for biopharmaceutical companies when planning their clinical trial material and/or drug...

READ MORE
WANT MORE INFORMATION?

Learn more about Emergent CDMO’s work and the many milestones we’ve reached in our news release archive below.  If you’re a media representative, please feel free to contact us at cdmo@ebsi.com.

Interested in learning more about Emergent BioSolutions, Inc.? Please visit emergentbiosolutions.com.

WANT MORE INFORMATION?

Learn more about Emergent CDMO’s work and the many milestones we’ve reached in our news release archive below.  If you’re a media representative, please feel free to contact us at mediarelations@ebsi.com.

Interested in learning more about Emergent BioSolutions, Inc.? Please visit emergentbiosolutions.com.